David Lewis

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst David Lewis works at MORGAN STANLEY and is focused on the Healthcare sector with 702 price targets and ratings documented since 2012 spanning on 23 stocks. Analyst's average stock valuation to be materialised ratio is 84.52% with an average time for price targets to be met of 251.36 days.

Most recent stock forecast was given on PODD, Insulet Corporation at 04-Nov-2022.

David Lewis best performing recommendations are on SWAV (SHOCKWAVE MEDICAL, INC).
The best stock recommendation documented was for NVRO (NEVRO CORP) at 11/6/2018. The price target of $43 was fulfilled within 2 days with a profit of $4.85 (12.71%) receiving and performance score of 63.56.

Average potential price target upside

of $40.44 (20.19%) on BDX (BECTON, DICKINSON AND COMPANY).
of $35.37 (21.62%) on SYK (STRYKER CORPORATION).
of $33.48 (31.2%) on ZBH (ZIMMER BIOMET HOLDINGS, INC).

Currently, out of the existing stock ratings of David Lewis - 20096 which are a Hold (45.26%), 21552 which are a Buy (48.54%), 2756 which are a Sell (6.21%)